NPPA hikes ceiling prices of 21 formulations by 50%
Saturday, December 14, 2019, 8:29 AM
In a major development that would help drug makers to tide over the high costs of active pharmaceutical ingredients (APIs) and intermediates, the NPPA has increased the ceiling price of 21 formulations by 50% on December 13. NPPA said it has been receiving applications for an upward revision of prices under para 19 of the DPCO, 2013, since the last two years.
Prices of 390 non-scheduled cancer medicines slashed by up to 87%: Govt
Friday, March 8, 2019, 8:51 PM
The maximum retail price of 390 non-scheduled cancer medicines have been reduced by up to 87 per cent, which would result in annual savings of around Rs 800 crore for the patients, the government said Friday. The National Pharmaceutical Pricing Authority (NPPA) on February 27 had brought 42 non-scheduled anti-cancer drugs under price control, capping trade margin at 30 percent.